LM Advisors LLC Increases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

LM Advisors LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,088 shares of the exchange traded fund’s stock after purchasing an additional 254 shares during the quarter. LM Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $818,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in XBI. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $29,000. Kohmann Bosshard Financial Services LLC acquired a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $29,000. Avior Wealth Management LLC boosted its position in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the period. Lee Danner & Bass Inc. purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $38,000. Finally, Bank of Jackson Hole Trust purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Trading Down 2.3 %

XBI stock opened at $85.08 on Thursday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The company’s 50 day moving average is $89.52 and its two-hundred day moving average is $94.12. The stock has a market cap of $5.52 billion, a P/E ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were issued a dividend of $0.0053 per share. The ex-dividend date was Monday, March 24th.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.